Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Representative before the EPO

Employment test 11 - 50 employees
Company dna kraus and weisert patentanwalte partgmbb
operating since 1974
Headquarter in Munich
active in Legal Services and IP Consulting

Oliver Ladendorf has worked on the following 38 EPO patent applications which have been published in the last five years:

EP13172175

Beverage compositions

IPC classification:
A23F 3/14
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13738479

MAGNETIC NANOPARTICLE-SAMIRNA COMPLEX AND METHOD FOR PREPARING SAME

IPC classification:
A61K 9/16, A61K 31/7088, A61K 31/7105, A61K 47/48
Applicant:
Bioneer Corporation
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13743292

INNERVATION OF ENGINEERED STRUCTURES

IPC classification:
A61F 2/08, A61L 27/38, C12N 5/07
Applicant:
Wake Forest University Health Sciences
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12852618

CULTURE-MEDIUM COMPOSITION FOR REJUVENATING STEM CELLS

IPC classification:
C12N 1/38, C12N 5/02, C12N 5/0775
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13747196

TREATING WASTE STREAMS WITH ORGANIC CONTENT

IPC classification:
C02F 1/52
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13768152

METHODS FOR TREATING NEOPLASIA

IPC classification:
A61K 31/337, A61K 38/17, A61K 38/20, A61P 35/00
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13775784

METHOD AND COMPOSITION FOR PREVENTING STEM CELL DISRUPTION AND AGGREGATION

IPC classification:
A61K 35/12, C12N 5/074, C12N 5/0775
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13794539

RNA-INTERFERENCE-INDUCING NUCLEIC ACID MOLECULE ABLE TO PENETRATE INTO CELLS, AND USE THEREFOR

IPC classification:
A61K 48/00, C12N 15/113, C12N 15/63
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13793331

NUCLEIC ACID AMPLIFICATION AND USE THEREOF

IPC classification:
C12N 15/11, C12Q 1/68
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13786285

MEANS AND METHODS FOR IDENTIFYING RIBOSOME ASSOCIATED RNA MOLECULES

IPC classification:
C12Q 1/68
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13857338

DUAL-TARGET ANTIBODY TARGETING VEGFR-2 AND DLL4, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

IPC classification:
A61K 39/395, C07K 16/46, C07K 19/00, C12N 15/62
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13812385

USE OF PROBES FOR MASS SPECTROMETRIC IDENTIFICATION OF MICROORGANISMS OR CELLS AND ASSOCIATED CONDITIONS OF INTEREST

IPC classification:
C12Q 1/68
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13814963

STABLE TRANSFORMATION OF A POPULATION AND A METHOD OF BIOCONTAINMENT USING HAPLOINSUFFICIENCY AND UNDERDOMINANCE PRINCIPLES

IPC classification:
A01H 1/00, A01K 67/033
Applicant:
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP14708425

TUBERCULOSIS BIOMARKERS AND USES THEREOF

IPC classification:
G01N 33/50, G01N 33/569, G01N 33/68
Applicant:
Albert Einstein College of Medicine Inc.
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14792262

MONOCLONAL ANTIBODY RECOGNIZING SIALYLATED SUGAR CHAINS

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18, C12N 5/10, C12P 21/08, G01N 33/53, G01N 33/574, G01N 33/577
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14791926

IMMUNITY INDUCER FOR SACCHARIDE ANTIGENS

IPC classification:
A61K 31/702, A61K 39/00, A61P 37/04, C07H 15/02, C07K 16/00, C08B 37/00
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14797400

PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES

IPC classification:
A61K 48/00
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14773781

PHOTORESPONSIVE NUCLEOTIDE ANALOGUE HAVING PHOTOCROSSLINKING ABILITY

IPC classification:
C07D 209/86, C07H 19/06, C08F 230/02
Applicant:
Japan Science and Technology Agency
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14807026

MALARIA VACCINE

IPC classification:
A61K 39/015, C07K 14/18, C07K 14/445, C07K 19/00, C12N 7/00, C12N 15/09
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14823421

METHOD FOR DIAGNOSIS OF DISEASES USING MORPHOLOGICAL CHARACTERISTICS OF LUTERIAL

IPC classification:
G01N 33/48, G01N 33/53, G01N 33/58
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14823398

VIRUS LIKE PARTICLE COMPRISING PD-1 ANTIGEN OR PD-1 LIGAND ANTIGEN

IPC classification:
C12N 7/00
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14780963

MULTIFUNCTIONAL RNA NANOPARTICLES AND METHODS OF USE

IPC classification:
A61K 47/48, C12N 15/11, C12N 15/87
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14853355

ALPHA HELIX CELL-PENETRATING PEPTIDE MULTIMER, PREPARATION METHOD THEREFOR AND USE THEREOF

IPC classification:
A61K 47/42, C07K 7/02
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14858942

METHOD OF SUPPRESSING FORMATION OF PHOTOCROSSLINK, AND PHOTOREACTIVE NUCLEIC ACID IN WHICH AUTO-CROSSLINK FORMATION IS SUPPRESSED

IPC classification:
C07H 19/073, C07H 21/04, C12N 15/09
Applicant:
Japan Science and Technology Agency
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP13178086

Method for diagnosing acute renal failure or chronic renal failure

IPC classification:
A01N 1/02, A61K 38/17
Applicant:
Children's Medical Center Corporation
Agent:
Oliver Ladendorf, Maiwald Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14878548

LUTERIAL AND METHOD FOR ISOLATING AND CULTURING SAME

IPC classification:
C12N 1/00, C12Q 1/24
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15737047

METHOD FOR SCREENING CANCER PREVENTION AGENT OR ANTICANCER AGENT USING MORPHOLOGICAL CHARACTERISTICS OF LUTERIAL

IPC classification:
G01N 33/48, G01N 33/53, G01N 33/574
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP16736753

ANTICANCER FUNCTIONAL PEPTIDE FOR INHIBITING PROLIFERATION OF CANCER STEM CELL, AND USE THEREOF

IPC classification:
A61K 9/00, A61K 38/10, A61K 47/30
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15765147

METHODS FOR PREPARATION OF A TERMINALLY STERILIZED HYDROGEL DERIVED FROM EXTRACELLULAR MATRIX

IPC classification:
A61L 27/36, A61L 27/52
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14887849

MELTING CURVE ANALYSIS USING PNA PROBE, METHOD AND KIT FOR ANALYZING NUCLEOTIDE POLYMORPHISM USING MELTING CURVE ANALYSIS

IPC classification:
C12Q 1/68
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15779735

CODON OPTIMIZED NUCLEIC ACID ENCODING A RETINITIS PIGMENTOSA GTPASE REGULATOR (RPGR)

IPC classification:
C12N 9/00, C12N 15/00, C12N 15/64, C12P 21/06
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15825418

METHOD FOR POSITIONING, IN CYTOPLASM, ANTIBODY HAVING COMPLETE IMMUNOGLOBULIN FORM BY PENETRATING ANTIBODY THROUGH CELL MEMBRANE, AND USE FOR SAME

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/32, C07K 16/46, A61K 47/50
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15825508

METHOD FOR SUPPRESSING RAS ACTIVATED IN CELL BY USING ANTIBODY HAVING CYTOPLASM PENETRATION CAPACITY AND COMPLETE IMMUNOGLOBULIN FORM, AND USE FOR SAME

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/32, C07K 16/46, C12N 15/13, G01N 33/53, A61K 47/50
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15829311

VIRUS LIKE PARTICLE COMPRISING MODIFIED ENVELOPE PROTEIN E3

IPC classification:
A61K 39/12, A61P 31/00, A61P 35/00, A61P 37/02, C12N 5/10, C12N 7/00, C12N 15/09
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15818206

COMPOSITION FOR PROMOTING STORAGE STABILITY OF STEM CELLS

IPC classification:
A01N 1/02
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP16195913

SV82 POLYPEPTIDE, AND COSMETIC COMPOSITION FOR REDUCING SKIN WRINKLES AND MAINTAINING SKIN ELASTICITY COMPRISING SV82 POLYPEPTIDE AS ACTIVE INGREDIENT

IPC classification:
A61K 8/64, A61Q 19/08
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15840429

FLAVIVIRUS VIRUS LIKE PARTICLE

IPC classification:
C07K 19/00, C12N 15/09
Agent:
Oliver Ladendorf, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made

Please Sign in to use this feature